As the USA faces a worsening overdose crisis, improving access to evidence-based
treatment for opioid use disorder (OUD) remains a policy priority. Federal regulatory …

We review quasi-experimental studies that examine the relationship of opioids to health,
healthcare, and crime in the US Our findings align with the general perception that the …

Background This study examines the effects of COVID-19 related restrictions on the supply
of illicit drugs, drug-use behaviour among people who use drugs (PWUD) regularly (at least …

Objective To understand patient experience of federal regulatory changes governing
methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic …

Background The coronavirus pandemic resulted in many changes which had the potential to
impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine) …

Introduction A recent surge in HIV outbreaks, driven by the opioid and stimulant use crises,
has destabilized our progress toward targets set forth by Ending the HIV Epidemic: A Plan …

Objectives The COVID-19 pandemic significantly impacted mental health, health-related
behaviours such as drinking and illicit drug use and the accessibility of health and social …

Background Drug overdoses surged during the COVID-19 pandemic, underscoring the need
for expanded and accessible substance use disorder (SUD) treatment. Relatively little is …

Objectives This study describes harm reduction and health services provided by US syringe
services programs (SSPs) in 2019 and changes in provision of those services in 2020 …

Kratom (Mitragyna speciosa, Korth.) is an evergreen tree that is indigenous to Southeast
Asia. When ingested, kratom leaves or decoctions from the leaves have been reported to …